Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biosimilars and Biobetters

29 Sep 2014 - 30 Sep 2014 - London, UK



Bookmark and Share


The industry leading Biosimilars & Biobetters Conference for combining new biosimilars and biobetter developments with essential networking opportunities, will be taking place in London, on the 29th-30th of September 2014. 

With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.

Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding biosimilar commercial and manufacturing developments.

KEY TOPICS INCLUDE:

  • Optimizing the commercial potential of biosimilars in Europe 
  • The big guns are coming! ...how will the entry of originator companies impact the biosimilars industry 
  • What is on the horizon? ... Reviewing the opportunities and challenges for the biopharmaceutical industry 
  • Christening day…but what shall we call you! Discussing the ongoing debate on naming biosimilars... and much more!

KEY SPEAKERS INCLUDE:

  • Alan Sheppard, Global Head Generics, Thought Leadership, IMS Health 
  • Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals 
  • Uwe Gudat, Head of Safety Biosimilars, Merck Switzerland Limited 
  • Catherine Akers, Regulatory Affairs Manager, Amgen Inc  
  • Carsten Brockmeyer, Founder, Formycon AG 
  • Rakesh Dixit, Vice President, R&D, Global Head, Biologics Safety Assessment, Medimmune (AstraZeneca Biologics) 
  • Ineke Braat, CEO, Pan-Generika 
  • Sharma Alok, Principal Scientist & Head Analytical Development, Lupin Laboratories Ltd 
  • Steinar Madsen, Medical Director, Norwegian Medicines Agency 
  • Peter Wittner, Senior Consultant, Interpharm Consultancy 
  • Sarah Faircliffe, Legal Director, Bird & Bird...

Plus, many more at this year's event.

For more information, contact Fateja Begum on +44 (0) 207 827 6184 or e-mail fbegum@smi-online.co.uk

For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or e-mail amalick@smi-online.co.uk

Event website: www.smi-online.co.uk/2014biosimilars65.asp



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!